BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33917547)

  • 1. Molecular Mechanisms of Maternal Diabetes Effects on Fetal and Neonatal Surfactant.
    Yildiz Atar H; Baatz JE; Ryan RM
    Children (Basel); 2021 Apr; 8(4):. PubMed ID: 33917547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal morbidity and mortality in offspring of diabetic mothers in Qatif, Saudi Arabia.
    al-Dabbous IA; Owa JA; Nasserallah ZA; al-Qurash IS
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):165-9. PubMed ID: 8730618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal lung development in the diabetic pregnancy.
    Bourbon JR; Farrell PM
    Pediatr Res; 1985 Mar; 19(3):253-67. PubMed ID: 3885150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-range complications in offspring of diabetic mothers.
    Weintrob N; Karp M; Hod M
    J Diabetes Complications; 1996; 10(5):294-301. PubMed ID: 8887019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M; Sledziewski A; Kretowski A
    Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of chronic exposure to glucose or sodium butyrate on surfactant development in fetal rabbits.
    Tshiyombo TD; Oulton MR
    J Perinat Med; 2001; 29(6):476-85. PubMed ID: 11776678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive value of fetal lung maturation tests.
    Kjos SL; Walther FJ; Montoro M; Paul RH; Diaz F; Stabler M
    Am J Obstet Gynecol; 1990 Sep; 163(3):898-903. PubMed ID: 2144951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5-Dimethyl-3'-isopropyl-l-thyronine therapy in diabetic pregnancy: stimulation of rabbit fetal lung phospholipids.
    Neufeld N; Melmed S
    J Clin Invest; 1981 Dec; 68(6):1605-9. PubMed ID: 7033290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Animal experiment and clinical studies of the significance of carnitine for energy metabolism in pregnant patients and the fetus during the pre- and perinatal period].
    Lohninger A; Laschan C; Auer B; Linhart L; Salzer H
    Wien Klin Wochenschr; 1996; 108(2):33-9. PubMed ID: 8835430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal complications in infants born to diabetic mothers.
    Alam M; Raza SJ; Sherali AR; Akhtar AS
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):212-5. PubMed ID: 16542603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine hyperglycemia-induced inflammatory signalling via the receptor for advanced glycation end products in the cardiac muscle of the infants of diabetic mother rats.
    Kawaharada R; Masuda H; Chen Z; Blough E; Kohama T; Nakamura A
    Eur J Nutr; 2018 Dec; 57(8):2701-2712. PubMed ID: 28942514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H; Monset-Couchard M
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of a Maternal High-Fat Diet and Late Gestation Diabetes on the Developing Rat Lung.
    Baack ML; Forred BJ; Larsen TD; Jensen DN; Wachal AL; Khan MA; Vitiello PF
    PLoS One; 2016; 11(8):e0160818. PubMed ID: 27518105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM
    Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in surfactant protein A mRNA levels in a rat model of insulin-treated diabetic pregnancy.
    Moglia BB; Phelps DS
    Pediatr Res; 1996 Feb; 39(2):241-7. PubMed ID: 8825794
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.